A few days vs nine months, it's not optimization but refactoring, medical AI has finally entered the deep water zone

Astraea is an AI-native platform designed to automate the biostatistics workflows of clinical trials. By inputting raw data, trial protocols, and metadata, it automatically generates SDTM and ADaM datasets, TFL and FDA-ready outputs that comply with CDISC standards. Traditional processes typically take 9 months and involve a team of 5-10 people, while this platform can complete the task within days. It currently focuses on oncology and rare diseases, and is led by co-founders Joshua Wang (CEO) and Sanmay Sarada (CTO), both with backgrounds from Stanford, with support from YC.